Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

331 ARTÍCULOS , VIENDO DEL 16 AL 30

[Multifunctional ligands--a new approach in the search for drugs against multi-factorial diseases]

Wichur T, Malawska B.

Postepy Hig Med Dosw (Online). 2015 Jan 2;69:1423-34.

Critical analysis of Alzheimer's amyloid-beta toxicity to mitochondria

Kaminsky YG, Tikhonova LA, Kosenko EA.

Front Biosci (Landmark Ed). 2015 Jan 1;20(1):173-97. doi: 10.2741/4304.

Brain metabolism and Alzheimer's disease: the prospect of a metabolite-based therapy

Thomas SC, Alhasawi A, Appanna VP, Auger C, Appanna VD.

J Nutr Health Aging. 2015 Jan;19(1):58-63. doi: 10.1007/s12603-014-0511-7.

A novel prescription for Alzheimer's disease: targeting hypercoagulable states

Maiese K.

Curr Neurovasc Res. 2015;12(1):1-3. doi: 10.2174/1567202612666150107162329.

Pin1 dysregulation helps to explain the inverse association between cancer and Alzheimer's disease

Driver JA, Zhou XZ, Lu KP.

Biochim Biophys Acta. 2015 Oct;1850(10):2069-76. doi: 10.1016/j.bbagen.2014.12.025. Epub 2015 Jan 10.

Receptor for advanced glycation endproduct modulators: a new therapeutic target in Alzheimer's disease

Walker D, Lue LF, Paul G, Patel A, Sabbagh MN.

Expert Opin Investig Drugs. 2015 Mar;24(3):393-9. doi: 10.1517/13543784.2015.1001490. Epub 2015 Jan 14.

Predictive factors of clinical response to cholinesterase inhibitors in mild and moderate Alzheimer's disease and mixed dementia: a one-year naturalistic study

Miranda LF, Gomes KB, Silveira JN, Pianetti GA, Byrro RM, Peles PR, Pereira FH, Santos TR, Assini AG, Ribeiro VV, Tito PA, Matoso RO, Lima TO, Moraes EN, Caramelli P.

J Alzheimers Dis. 2015;45(2):609-20. doi: 10.3233/JAD-142148.

Donepezil decreases annual rate of hippocampal atrophy in suspected prodromal Alzheimer's disease

Dubois B, Chupin M, Hampel H, Lista S, Cavedo E, Croisile B, Louis Tisserand G, Touchon J, Bonafe A, Ousset PJ, Ait Ameur A, Rouaud O, Ricolfi F, Vighetto A, Pasquier F, Delmaire C, Ceccaldi M, Girard N, Dufouil C, Lehericy S, Tonelli I, Duveau F, Colliot O, Garnero L, Sarazin M, Dormont D; “Hippocampus Study Group”; Hippocampus Study Group.

Alzheimers Dement. 2015 Sep;11(9):1041-9. doi: 10.1016/j.jalz.2014.10.003. Epub 2015 Jan 14.

A systems approach to drug discovery in Alzheimer's disease

Shelanski M, Shin W, Aubry S, Sims P, Alvarez MJ, Califano A.

Neurotherapeutics. 2015 Jan;12(1):126-31. doi: 10.1007/s13311-014-0335-5.

The potent BACE1 inhibitor LY2886721 elicits robust central Aβ pharmacodynamic responses in mice, dogs, and humans

May PC, Willis BA, Lowe SL, Dean RA, Monk SA, Cocke PJ, Audia JE, Boggs LN, Borders AR, Brier RA, Calligaro DO, Day TA, Ereshefsky L, Erickson JA, Gevorkyan H, Gonzales CR, James DE, Jhee SS, Komjathy SF, Li L, Lindstrom TD, Mathes BM, Martényi F, Sheehan SM, Stout SL, Timm DE, Vaught GM, Watson BM, Winneroski LL, Yang Z, Mergott DJ.

J Neurosci. 2015 Jan 21;35(3):1199-210. doi: 10.1523/JNEUROSCI.4129-14.2015.

Screening strategies to identify HSP70 modulators to treat Alzheimer's disease

Repalli J, Meruelo D.

Drug Des Devel Ther. 2015 Jan 7;9:321-31. doi: 10.2147/DDDT.S72165. eCollection 2015.

Characterization of hepatic enzyme activity in older adults with dementia: potential impact on personalizing pharmacotherapy

Campbell NL, Skaar TC, Perkins AJ, Gao S, Li L, Khan BA, Boustani MA.

Clin Interv Aging. 2015 Jan 14;10:269-75. doi: 10.2147/CIA.S65980. eCollection 2015.

MicroRNA landscape in Alzheimer's disease

Cogoni C, Ruberti F, Barbato C.

CNS Neurol Disord Drug Targets. 2015;14(2):168-75. doi: 10.2174/1871527314666150116123305.

Effects of n-3 FA supplementation on the release of proresolving lipid mediators by blood mononuclear cells: the OmegAD study

Wang X, Hjorth E, Vedin I, Eriksdotter M, Freund-Levi Y, Wahlund LO, Cederholm T, Palmblad J, Schultzberg M.

J Lipid Res. 2015 Mar;56(3):674-681. doi: 10.1194/jlr.P055418. Epub 2015 Jan 23.

Oxidative Stress in Alzheimer's Disease: Should We Keep Trying Antioxidant Therapies?

Ferreira ME, de Vasconcelos AS, da Costa Vilhena T, da Silva TL, da Silva Barbosa A, Gomes AR, Dolabela MF, Percário S.

Cell Mol Neurobiol. 2015 Jul;35(5):595-614. doi: 10.1007/s10571-015-0157-y. Epub 2015 Jan 24.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias